UA96260C2 - Режим применения кладрибина для лечения рассеянного склероза - Google Patents
Режим применения кладрибина для лечения рассеянного склерозаInfo
- Publication number
- UA96260C2 UA96260C2 UAA200708371A UAA200708371A UA96260C2 UA 96260 C2 UA96260 C2 UA 96260C2 UA A200708371 A UAA200708371 A UA A200708371A UA A200708371 A UAA200708371 A UA A200708371A UA 96260 C2 UA96260 C2 UA 96260C2
- Authority
- UA
- Ukraine
- Prior art keywords
- multiple sclerosis
- treating multiple
- cladribine
- regimen
- cladribine regimen
- Prior art date
Links
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 title abstract 2
- 229960002436 cladribine Drugs 0.000 title abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 abstract 1
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000008628 secondary progressive multiple sclerosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Pressure Welding/Diffusion-Bonding (AREA)
Abstract
Данное изобретение касается применения кладрибина для приготовления фармацевтической композиции для лечения рассеянного склероза, где эта композиция должна быть применена перорально с соблюдением определенных последовательных этапов.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106909 | 2004-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA96260C2 true UA96260C2 (ru) | 2011-10-25 |
Family
ID=34930135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200708371A UA96260C2 (ru) | 2004-12-22 | 2005-12-20 | Режим применения кладрибина для лечения рассеянного склероза |
Country Status (11)
| Country | Link |
|---|---|
| AT (1) | ATE547106T1 (ru) |
| CY (1) | CY1125491T1 (ru) |
| DK (1) | DK1827461T3 (ru) |
| ES (4) | ES2666146T3 (ru) |
| HU (1) | HUE035859T2 (ru) |
| LT (1) | LT2805723T (ru) |
| ME (1) | ME01333B (ru) |
| PT (4) | PT1827461E (ru) |
| RS (1) | RS52219B (ru) |
| SI (1) | SI1827461T1 (ru) |
| UA (1) | UA96260C2 (ru) |
-
2005
- 2005-12-20 RS RS20120161A patent/RS52219B/sr unknown
- 2005-12-20 AT AT05823474T patent/ATE547106T1/de active
- 2005-12-20 DK DK05823474.1T patent/DK1827461T3/da active
- 2005-12-20 UA UAA200708371A patent/UA96260C2/ru unknown
- 2005-12-20 ES ES14001970.4T patent/ES2666146T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT05823474T patent/PT1827461E/pt unknown
- 2005-12-20 SI SI200531514T patent/SI1827461T1/sl unknown
- 2005-12-20 LT LTEP14001970.4T patent/LT2805723T/lt unknown
- 2005-12-20 ES ES10182676.6T patent/ES2495392T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT181516345T patent/PT3332789T/pt unknown
- 2005-12-20 PT PT221666100T patent/PT4070800T/pt unknown
- 2005-12-20 ES ES05823474T patent/ES2382554T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT140019704T patent/PT2805723T/pt unknown
- 2005-12-20 HU HUE14001970A patent/HUE035859T2/en unknown
- 2005-12-20 ES ES10182632T patent/ES2428741T3/es not_active Expired - Lifetime
- 2005-12-20 ME MEP-2012-35A patent/ME01333B/me unknown
-
2022
- 2022-06-21 CY CY20221100424T patent/CY1125491T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2666146T3 (es) | 2018-05-03 |
| SI1827461T1 (sl) | 2012-05-31 |
| RS52219B (sr) | 2012-10-31 |
| HUE035859T2 (en) | 2018-05-28 |
| LT2805723T (lt) | 2018-02-12 |
| DK1827461T3 (da) | 2012-03-26 |
| ES2495392T3 (es) | 2014-09-17 |
| PT3332789T (pt) | 2022-07-05 |
| CY1125491T1 (el) | 2025-05-09 |
| ES2428741T3 (es) | 2013-11-11 |
| PT2805723T (pt) | 2018-01-25 |
| PT1827461E (pt) | 2012-05-07 |
| ES2382554T3 (es) | 2012-06-11 |
| PT4070800T (pt) | 2024-12-30 |
| ME01333B (me) | 2013-12-20 |
| ATE547106T1 (de) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073813L (no) | Kladribinregime for behandling av multippel sklerose | |
| TW200635923A (en) | Tricyclic heterocycles, their manufacture and use as pharmaceutical agents | |
| TW200508214A (en) | Novel compounds | |
| TW200619220A (en) | New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5, 6, 7, 8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
| TW200640908A (en) | Chemical compounds | |
| TW200621730A (en) | Chemical compounds | |
| MY141025A (en) | Dose forms | |
| TW200616974A (en) | Chemical compounds | |
| WO2007135172A3 (en) | Cladribine regimen for treating multiple sclerosis | |
| TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
| TW200621259A (en) | Chemical compounds | |
| PL372457A1 (en) | New pharmaceutical compositions containing flibanserin polymorph a | |
| ATE331711T1 (de) | Entzündungshemmende 3-arylthio-3- thiazolylalkylamine | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| MY146802A (en) | Novel drugs for treating respiratory diseases | |
| PT3332789T (pt) | Regime de cladribina para o tratamento de esclerose múltipla | |
| MX2009005125A (es) | Pirrolo[1,2-a]imidazoldiona efectiva en el tratamiento de neurotoxicidad periferica inducida por agentes quimioterapeuticos. | |
| UA91694C2 (ru) | Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций | |
| TW200634002A (en) | Chemical compounds | |
| BRPI0618370A2 (pt) | formulação aerossol de medicamento, uso do mesmo e kit de inalação | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
| TW200626149A (en) | Tricycles, their manufacture and use as pharmaceutical agents |